Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media
APMIS · 2024
DOI: 10.1111/apm.13413 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2024. Verfasst von Adrian Jimenez San San Mauro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology & Microbiology, Costerton Biofilm Center, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Azithromycin, Microbial Sensitivity Tests. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Azithromycin (AZM) is efficient for treatment of chronic Pseudomonas aeruginosa biofilm lung infections, despite of resistance in conventional susceptibility testing. It has been shown that planktonic P. aeruginosa are more susceptible to AZM when tested in RPMI 1640 medium. The aim of the study was to test the susceptibility to AZM of P. aeruginosa biofilms in LB vs RPMI 1640 media. We investigated the effect of AZM on planktonic and biofilms of (WT) P. aeruginosa (PAO1), the hypermutable (Δ mutS ) and the antibiotic‐resistant phenotype(Δ nfxB ) mutants. The effect of AZM on young and mature biofilms was investigated in the modified Calgary Biofilm Device by estimation of the minimal biofilm inhibitory concentration (MBIC). The AZM MBIC 90 in LB/RPMI1640 on young biofilms treated for 24 h was 16/4 μg/mL for PAO1, 32/8 μg/mL for Δ mutS, and 256/16 μg/mL for Δ nfxB, while in mature biofilms was 256/2 μg/mL for PAO1 and Δ mutS and 16/1 μg/mL for Δ nfxB. The effect of AZM was improved when the treatment was prolonged to 72 h, supporting the intracellular accumulation of AZM. An increased susceptibility of P. aeruginosa biofilms to AZM was observed in RPMI 1640 than in LB medium. Our results might improve susceptibility testing and dosing of AZM for treatment of biofilm infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology & Microbiology, Costerton Biofilm Center, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Oana Ciofu
Zitieren
APA
San Mauro, A. J. S., Høiby, N., & Ciofu, O. (2024). Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media. APMIS. https://doi.org/10.1111/apm.13413
Vancouver
San Mauro AJS, Høiby N, Ciofu O. Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media. APMIS. 2024. doi:10.1111/apm.13413
BibTeX
@article{SanMauro2024,
author = {San Mauro, Adrian Jimenez San and Høiby, Niels and Ciofu, Oana},
title = {Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media},
journal = {APMIS},
year = {2024},
doi = {10.1111/apm.13413}
}
EUVIMED